Evidence map›Paper›PMID 20509670›Full record

ArticleACS nano2010

Assembly mechanism of the sixty-subunit nanoparticles via interaction of RNA with the reengineered protein connector of phi29 DNA-packaging motor.

Feng Xiao, Borries Demeler, Peixuan Guo

Open access · bronzeAbstract read
In one paragraph

Article in ACS nano, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. RNA nanotechnology for computer design and in vivo computation.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2013
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The emerging field of RNA nanotechnology.Nature nanotechnology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Feng XiaoDepartment of Biomedical Engineering, College of Engineering/College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA.
Borries Demeler
Peixuan Guo
University of Cincinnati Medical Center · USThe University of Texas Health Science Center at San Antonio · US

Funding

STRUCTURE/FUNCTION OF PHI29 HEXAMERIC PRNAR01GM059944 · NIGMS · UNIVERSITY OF CINCINNATI · PI GUO, PEIXUAN · 1999 to 2009
$1.9M
UltraScan Software Maintenance and DevelopmentR01RR022200 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DEMELER, BORRIES · 2007 to 2010
$1.7M
NCRR NIH HHS R01 RR022200NCRR NIH HHS R01-RR0222000NIGMS NIH HHS R01 GM059944NIGMS NIH HHS R01-GM59944
6 · The paper itself

Abstract

Bacterial virus phi29 genomic DNA is packaged into a procapsid shell with the aid of a motor containing a 12-subunit connector channel and a hexameric pRNA (packaging RNA) ring. The wide end, or the C-terminus, of the cone-shaped connector is embedded within the procapsid shell, whereas the narrow end, or N-terminus, extends outside of the procapsid, providing a binding location for pRNA. Recently, we have reported the mechanism of in vivo assembly of an ellipsoid nanoparticle with seven connectors through an interaction among a peptide tag. Here we report the formation of a similar nanoparticle in vitro via the addition of DNA or RNA oligos to connector proteins. Free connectors guided by one or two copies of oligonucleotides were assembled into a rosette structure containing 60 subunits of reengineered proteins. The number of oligonucleotides within the particle is length-dependent but sequence-independent. Reversible shifting between the 12- and 60-subunit nanoparticles (between individual connectors and rosette structures, respectively) was demonstrated by the alternative addition of oligonucleotides and the treatment of ribonuclease, suggesting a potential application as a switch or regulator in nanobiotechnology. This advancement allows for a simple method to produce multivalent nanoparticles that contain five 12-unit nanoparticles with defined structure and stoichiometry. That is, it will be possible to assemble nanoparticles in vitro with the combination of 60 assortments of ligands, tags, therapeutic drugs, and diagnostic moieties for multivalent delivery or enhancement of signal detection in nanotechnological and nanomedicinal applications.

Indexed as

BacteriophagesBinding SitesCrystallizationDNA, ViralMacromolecular SubstancesMaterials TestingMolecular ConformationMolecular Motor ProteinsNanostructuresNanotechnologyParticle SizeProtein EngineeringRNASurface PropertiesDNA, ViralMacromolecular SubstancesMolecular Motor ProteinsRNA

Identifiers

PMID20509670
PMCPMC2889630
OpenAlexW2046366133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.